DCF — TEXOMA MEDICAL CENTER
Enterprise Value: $14.2M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$14.2M
Enterprise Value
$-6.9M
PV of Cash Flows
$21.1M
PV of Terminal Value
$34.0M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $441.1M | $12.0M | 3.0% | $-6.9M | $-6.3M |
| Year 2 | $454.4M | $16.9M | 4.0% | $-3.7M | $-3.0M |
| Year 3 | $468.0M | $22.1M | 5.0% | $-0.3M | $-0.2M |
| Year 4 | $482.1M | $25.2M | 5.0% | $1.5M | $1.0M |
| Year 5 | $496.5M | $27.2M | 5.0% | $2.5M | $1.5M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $14.2M. Terminal value accounts for 149% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$428.3M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.02228967697702183
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5